VC  Mission BioCapital

https://www.missionbiocapital.com/





     Office Locations:

139 Main Street, Suite 401
Cambridge, MA 02142

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early


 

Industries:

  • Information Technology

  •  

    Description:

    Mission BioCapital is a VC firm making pivotal early-stage investments in biotech companies. Founded in 2009, the firm is investing out of its fifth fund. The firm's lab network can accommodate everything from the smallest company with a single lab bench all the way to teams with upwards of 30 employees. This offering of flexible lab space with top-of-the-line equipment allows entrepreneurs to streamline their infrastructure, focus on their science, and bring their novel treatments one step closer to patients.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Cassidy Blundell Principal
    Douglas Crawford Managing General Partner
    Eric Linsley General Partner
    Jennifer Griffin Partner
    Johannes Fruehauf General Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/23/2024


      March Biosciences


      TX


      $28,400,000


      Series A


      10/03/2024


      Integrated Biosciences


      CA


      $17,200,000


      Seed


      05/22/2024


      Progentos Therapeutics


      MA


      $65,000,000


      Series A


      03/04/2024


      Nocion Therapeutics


      MA


      $62,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: